Airway Tolerability

ULTANE® (sevoflurane) is nonpungent and does not cause respiratory irritability1,2

Airway Tolerability

ULTANE is the only fast-acting volatile inhalational agent suitable for mask induction in both adults and pediatric patients ≥1 year1

Safety Considerations1

Adverse events reported by ≥5% of the surgical patients receiving ULTANE during clinical trials during induction included: bradycardia, tachycardia, agitation, laryngospasm, airway obstruction, breathholding, and increased cough; during maintenance and emergence: shivering, hypotension, bradycardia, somnolence, agitation, nausea, vomiting, and increased cough were reported.

© 2023 AbbVie. All rights reserved.
ULTANE® and its design are registered trademarks of AbbVie Inc.

AbbVie logo